Gregory Burshtein's most recent trade in Entera Bio Ltd was a trade of 87,591 Ordinary Shares, par value NIS 0.0000769 per share done . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entera Bio Ltd | Gregory Burshtein | Chief of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 87,591 | 189,033 (1%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Gregory Burshtein | Chief of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Gregory Burshtein | Chief of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 26,316 | 101,442 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share |